Park Medi World quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Year before	Change
Revenue	476	—	—
EBITDA	126	—	—
EBITDA margin	26.5%	—	—
Profit before tax	105	—	—
Net profit	88.6	—	—
EPS	₹2.05	—	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025

Expenses
	476	460	410
	7.6	7.5	9.1
	483	468	419
	77.1	78.4	75.8
	−0.9	1.2	−0.1
	92.4	86.2	83.1
	9.8	14.0	14.9
	18.8	17.5	15.3
	181	167	152
	378	365	341
	126	127	99.4
	107	110	84.1
Profit
	105	103	78.3
	105	103	78.3
	25.8	19.8	19.1
	−9.3	6.8	6.4
	16.5	26.6	25.4
	88.6	76.8	52.8
	88.6	76.8	52.8
	−0.6	0.4	0.6
	88.0	77.2	53.4
	82.5	70.9	50.8
	6.1	5.9	2.1
Per share
	₹2.05	₹1.78	₹1.35
	₹2.05	₹1.78	₹1.35
Other comprehensive income — detail
	−0.6	0.4	0.6
	−0.8	0.4	0.7
	−0.2	0.0	0.2
	81.9	71.2	51.3
	6.1	5.9	2.1
Per share — as-filed variants
	₹2.05	₹1.78	₹1.35
	₹2.05	₹1.78	₹1.35
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	399	381	334
	84.0%	82.7%	81.5%
Adjusted (ex-exceptional items) — derived
	105	103	78.3
	88.6	76.8	52.8
	₹2.05	₹1.78	₹1.35

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PARKHOSPS₹221.25

Park Medi World Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersMAXHEALTH FORTIS MEDANTA METROPOLIS MARKSANS RUBICON JLHL SHILPAMEDMcap ₹9,556 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	410.0	460.4	475.7
Other Income	9.1	7.5	7.6
Total Income	419.1	467.9	483.4
Expenses
+ Cost of Materials Consumed	75.8	78.4	77.1
+ Changes in Inventories	-0.1	1.2	-0.9
+ Employee Benefit Expense	83.1	86.2	92.4
+ Finance Costs	14.9	14.0	9.8
+ Depreciation & Amortisation	15.3	17.5	18.8
+ Other Expenses	151.8	167.3	181.0
Total Expenses	340.8	364.5	378.3
EBITDA	99.4	127.4	126.1
EBIT	84.1	109.9	107.2
Profit
PBT before Exceptional Items	78.3	103.4	105.1
Pretax Income	78.3	103.4	105.1
+ Current Tax	19.1	19.8	25.8
+ Deferred Tax	6.4	6.8	-9.3
Tax Expense	25.4	26.6	16.5
Net Income	52.8	76.8	88.6
+ Net Income — Continuing Ops	52.8	76.8	88.6
+ Other Comprehensive Income	0.6	0.4	-0.6
Total Comprehensive Income	53.4	77.2	88.0
Net Income to Common	50.8	70.9	82.5
Minority Interest	2.1	5.9	6.1
Per Share
Basic EPS	1.35	1.78	2.05
Diluted EPS	1.35	1.78	2.05
Other Comprehensive Income — detail
+ Other Comprehensive Income	0.6	0.4	-0.6
+ Items NOT to be Reclassified to P&L	0.7	0.4	-0.8
+ Tax on Items NOT to be Reclassified	0.2	0.0	-0.2
Comprehensive Income — Owners of Parent	51.3	71.2	81.9
Comprehensive Income — Non-controlling Interests	2.1	5.9	6.1
Per Share — as-filed variants
Basic EPS — Continuing Operations	1.35	1.78	2.05
Diluted EPS — Continuing Operations	1.35	1.78	2.05
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	334.3	380.8	399.5
Gross Margin %	81.55	82.71	83.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	78.3	103.4	105.1
Net Income Adj (tax-effected)	52.8	76.8	88.6
EPS Adj	1.35	1.78	2.05
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00
Paid Up Equity Capital	86.4	86.4	86.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Park Medi World quarterly results

Park Medi World (NSE: PARKHOSPS) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit attributable to shareholders was ₹82.5 crore, up 16.4% from ₹70.9 crore in Q4 FY26. Revenue from operations was ₹476 crore, up 3.3% from the previous quarter.

Q1 FY27 results (the latest): 3 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹82.5 Cr+16.4% vs Q4 FY26
Q1 FY27 revenue: ₹476 Cr+3.3% vs Q4 FY26
Q1 FY27 operating margin: 22.5%−1.3 pts vs Q4 FY26
Q1 FY27 EPS (basic): ₹2.05

Questions

When will Park Medi World announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33).

What were Park Medi World's Q1 FY27 results?

Consolidated net profit attributable to shareholders was ₹82.5 crore, up 16.4% from ₹70.9 crore in Q4 FY26. Revenue from operations was ₹476 crore, up 3.3% from the previous quarter.

What was Park Medi World's net profit in FY26?

Consolidated net profit attributable to shareholders was ₹258 crore in FY26 (April 2025–March 2026).

What was Park Medi World's revenue in FY26?

Revenue from operations was ₹1,679 crore in FY26 (April 2025–March 2026).

Where do these Park Medi World figures come from?

From Park Medi World's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.